MiR-221 and miR-222, involved in the negative control of human erythropoiesis by blocking the C-Kit (S67773) gene [46], have been reported to be highly expressed in a variety of solid tumours including colon, pancreas, and prostate cancers [44], [47]. Here, KIT is linked to prostate cancer.